BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 27846402)

  • 1. Focal therapy in prostate cancer: A review of seven common controversies.
    Bass EJ; Ahmed HU
    Cancer Treat Rev; 2016 Dec; 51():27-34. PubMed ID: 27846402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focal therapy versus radical prostatectomy and external beam radiotherapy as primary treatment options for non-metastatic prostate cancer: results of a cost-effectiveness analysis.
    Reddy D; van Son M; Peters M; Bertoncelli Tanaka M; Dudderidge T; Cullen E; Ho CLT; Hindley RG; Emara A; McCracken S; Orczyk C; Shergill I; Mangar S; Nigam R; Virdi J; Moore CM; Arya M; Shah TT; Winkler M; Emberton M; Falconer A; Belsey J; Ahmed HU
    J Med Econ; 2023; 26(1):1099-1107. PubMed ID: 37656223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryotherapy for localised prostate cancer.
    Shelley M; Wilt TJ; Coles B; Mason MD
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005010. PubMed ID: 17636783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cryotherapy for localised or locally advanced prostate cancer.
    Jung JH; Risk MC; Goldfarb R; Reddy B; Coles B; Dahm P
    Cochrane Database Syst Rev; 2018 May; 5(5):CD005010. PubMed ID: 29845595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer.
    Kumar S; Shelley M; Harrison C; Coles B; Wilt TJ; Mason MD
    Cochrane Database Syst Rev; 2006 Oct; 2006(4):CD006019. PubMed ID: 17054269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal Therapy in Primary Localised Prostate Cancer: The European Association of Urology Position in 2018.
    van der Poel HG; van den Bergh RCN; Briers E; Cornford P; Govorov A; Henry AM; Lam TB; Mason MD; Rouvière O; De Santis M; Willemse PM; van Poppel H; Mottet N
    Eur Urol; 2018 Jul; 74(1):84-91. PubMed ID: 29373215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic options and controversies in the management of prostate cancer].
    Peyromaure M; Thiounn N
    Rev Prat; 2003 Dec; 53(20):2263-7. PubMed ID: 15018081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active surveillance and radical therapy in prostate cancer: can focal therapy offer the middle way?
    Ahmed HU; Emberton M
    World J Urol; 2008 Oct; 26(5):457-67. PubMed ID: 18704441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal therapy for prostate cancer: rationale and treatment opportunities.
    Kasivisvanathan V; Emberton M; Ahmed HU
    Clin Oncol (R Coll Radiol); 2013 Aug; 25(8):461-73. PubMed ID: 23759249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Effectiveness Analyses of Salvage Prostatectomy and Salvage Radiotherapy Outcomes Following Focal or Whole-Gland Ablative Therapy (High-Intensity Focused Ultrasound, Cryotherapy or Electroporation) for Localised Prostate Cancer.
    Nathan A; Ng A; Mitra A; Sooriakumaran P; Davda R; Patel S; Fricker M; Kelly J; Shaw G; Rajan P; Sridhar A; Nathan S; Payne H
    Clin Oncol (R Coll Radiol); 2022 Jan; 34(1):e69-e78. PubMed ID: 34740477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further Research.
    Bates AS; Ayers J; Kostakopoulos N; Lumsden T; Schoots IG; Willemse PM; Yuan Y; van den Bergh RCN; Grummet JP; van der Poel HG; Rouvière O; Moris L; Cumberbatch MG; Lardas M; Liew M; Van den Broeck T; Gandaglia G; Fossati N; Briers E; De Santis M; Fanti S; Gillessen S; Oprea-Lager DE; Ploussard G; Henry AM; Tilki D; van der Kwast TH; Wiegel T; N'Dow J; Mason MD; Cornford P; Mottet N; Lam TBL
    Eur Urol Oncol; 2021 Jun; 4(3):405-423. PubMed ID: 33423943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of localised prostate cancer].
    Jakobsen H; Iversen P; Mikines KJ; Nørgaard N; Høyer M
    Ugeskr Laeger; 2007 May; 169(20):1902-4. PubMed ID: 17553367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data.
    Vale CL; Fisher D; Kneebone A; Parker C; Pearse M; Richaud P; Sargos P; Sydes MR; Brawley C; Brihoum M; Brown C; Chabaud S; Cook A; Forcat S; Fraser-Browne C; Latorzeff I; Parmar MKB; Tierney JF;
    Lancet; 2020 Oct; 396(10260):1422-1431. PubMed ID: 33002431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy.
    Trock BJ; Han M; Freedland SJ; Humphreys EB; DeWeese TL; Partin AW; Walsh PC
    JAMA; 2008 Jun; 299(23):2760-9. PubMed ID: 18560003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of focal therapy in the management of localised prostate cancer: a systematic review.
    Valerio M; Ahmed HU; Emberton M; Lawrentschuk N; Lazzeri M; Montironi R; Nguyen PL; Trachtenberg J; Polascik TJ
    Eur Urol; 2014 Oct; 66(4):732-51. PubMed ID: 23769825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conventional radical versus focal treatment for localised prostate cancer: a propensity score weighted comparison of 6-year tumour control.
    van Son MJ; Peters M; Reddy D; Shah TT; Hosking-Jervis F; Robinson S; Lagendijk JJW; Mangar S; Dudderidge T; McCracken S; Hindley RG; Emara A; Nigam R; Persad R; Virdi J; Lewi H; Moore C; Orczyk C; Emberton M; Arya M; Ahmed HU; van der Voort van Zyp JRN; Winkler M; Falconer A
    Prostate Cancer Prostatic Dis; 2021 Dec; 24(4):1120-1128. PubMed ID: 33934114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Place of prostatectomy and radiotherapy in the treatment of cancer of the prostate confined to the prostate gland (T0, T1, T2)].
    Chopin DK; de Kernion JB
    Ann Urol (Paris); 1986; 20(2):83-9. PubMed ID: 3717904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localised prostate cancer - current treatment options.
    Duchesne G
    Aust Fam Physician; 2011 Oct; 40(10):768-71. PubMed ID: 22003477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study.
    Vergis R; Corbishley CM; Norman AR; Bartlett J; Jhavar S; Borre M; Heeboll S; Horwich A; Huddart R; Khoo V; Eeles R; Cooper C; Sydes M; Dearnaley D; Parker C
    Lancet Oncol; 2008 Apr; 9(4):342-51. PubMed ID: 18343725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ablative therapy for people with localised prostate cancer: a systematic review and economic evaluation.
    Ramsay CR; Adewuyi TE; Gray J; Hislop J; Shirley MD; Jayakody S; MacLennan G; Fraser C; MacLennan S; Brazzelli M; N'Dow J; Pickard R; Robertson C; Rothnie K; Rushton SP; Vale L; Lam TB
    Health Technol Assess; 2015 Jul; 19(49):1-490. PubMed ID: 26140518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.